CTLA4 and neoplasm: For instance, tumor-reactive CD4+ T cells can induce tumor rejection in mouse models when transplanted and treated with anti-CTLA-4, demonstrating that cytotoxic CD4+ T cells can directly target and destroy tumor cells.